The EBITDA margin stood at 33% in the reporting quarter compared to 32.7% a year ago. Shares of Caplin Point Laboratories Ltd ended at ₹2,212.25, up by ₹41.65, or 1.92%, on the BSE.
Your email address will not be published. Required fields are marked *
Name*
Email*
Website
Save my name, email, and website in this browser for the next time I comment.